Histaminergic regulation of food intake

Front Endocrinol (Lausanne). 2023 Jun 27:14:1202089. doi: 10.3389/fendo.2023.1202089. eCollection 2023.

Abstract

Histamine is a biogenic amine that acts as a neuromodulator within the brain. In the hypothalamus, histaminergic signaling contributes to the regulation of numerous physiological and homeostatic processes, including the regulation of energy balance. Histaminergic neurons project extensively throughout the hypothalamus and two histamine receptors (H1R, H3R) are strongly expressed in key hypothalamic nuclei known to regulate energy homeostasis, including the paraventricular (PVH), ventromedial (VMH), dorsomedial (DMH), and arcuate (ARC) nuclei. The activation of different histamine receptors is associated with differential effects on neuronal activity, mediated by their different G protein-coupling. Consequently, activation of H1R has opposing effects on food intake to that of H3R: H1R activation suppresses food intake, while H3R activation mediates an orexigenic response. The central histaminergic system has been implicated in atypical antipsychotic-induced weight gain and has been proposed as a potential therapeutic target for the treatment of obesity. It has also been demonstrated to interact with other major regulators of energy homeostasis, including the central melanocortin system and the adipose-derived hormone leptin. However, the exact mechanisms by which the histaminergic system contributes to the modification of these satiety signals remain underexplored. The present review focuses on recent advances in our understanding of the central histaminergic system's role in regulating feeding and highlights unanswered questions remaining in our knowledge of the functionality of this system.

Keywords: GPCR; food intake; histamine; histamine receptors; hypothalamus; leptin; melanocortin; neurometabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arcuate Nucleus of Hypothalamus
  • Brain
  • Eating
  • Humans
  • Hypothalamus* / physiology
  • Obesity*

Grants and funding

This research was supported by the Sentinel North Initiative funded by the Canada First Research Excellence Fund (Partnered Research Chair in Sleep Pharmacometabolism to NJM), the Fonds de recherche du Québec - Santé (FRQS) (J1 Research Scholar award to NJM), the Natural Sciences and Engineering Research Council of Canada (NSERC) (to NJM), the Fondation de l’Insitut Universitaire de Cardiologie et de Pneumologie de Québec (FIUCPQ) (to NJM and MMM), and the Canada Research Chairs Program (to AC).